Literature DB >> 6231907

Restenosis following transluminal angioplasty in experimental atherosclerosis.

D P Faxon, T A Sanborn, V J Weber, C Haudenschild, S B Gottsman, W A McGovern, T J Ryan.   

Abstract

Percutaneous transluminal angioplasty has received considerable attention in the treatment of obstructive atherosclerotic lesions in humans. However, restenosis frequently occurs and has limited the long-term effectiveness of this procedure. To study restenosis, a model of atherosclerosis was developed in 16 New Zealand rabbits. Atherosclerosis was induced in one or both iliac vessels by balloon deendothelialization followed by a 2% cholesterol diet for 6 weeks. Angiographic lesions were demonstrable in all animals. Fourteen iliac vessels served as controls, and nine underwent successful angioplasty with an increase in luminal diameter from 1.0 +/- 0.2 to 1.9 +/- 0.4 mm (p less than 0.01). After 4 weeks on a high cholesterol diet, all animals had another angiogram, which documented significant progression of disease in only six of 14 control iliac vessels, but in all nine dilated vessels. The average decrease in luminal diameter was 0.2 +/- 0.3 mm for the control group compared with 1.6 +/- 0.5 mm for the dilated group (p less than 0.01). Histopathological correlates revealed further remodeling of at various stages of organization and recanalization. In summary, this study demonstrates that restenosis occurs following transluminal angioplasty and is significantly more frequent than the natural progression of disease in a rabbit model of atherosclerosis. The mechanism of this restenosis appears to be related to intraluminal thrombosis and acceleration of atherosclerosis. Evaluation of antiplatelet drugs in the prevention of restenosis seems warranted.

Entities:  

Mesh:

Year:  1984        PMID: 6231907     DOI: 10.1161/01.atv.4.3.189

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  14 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  The Strecker stent: indications and results in iliac and femoropopliteal arteries.

Authors:  D Liermann; E P Strecker; J Peters
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

3.  Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries.

Authors:  R D Simari; H San; M Rekhter; T Ohno; D Gordon; G J Nabel; E G Nabel
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 4.  Pathogenesis of atherosclerosis: state of the art.

Authors:  C C Haudenschild
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

5.  Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury.

Authors:  J T Willerson; S K Yao; J McNatt; C R Benedict; H V Anderson; P Golino; S S Murphree; L M Buja
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 6.  Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention.

Authors:  L G Spagnoli; A Mauriello; A Orlandi; G Sangiorgi; E Bonanno
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

7.  Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries.

Authors:  D Liermann; H D Bottcher; J Kollath; B Schopohl; G Strassmann; E P Strecker; K H Breddin
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Jan-Feb       Impact factor: 2.740

Review 8.  Peripheral angioplasty balloon technology.

Authors:  A H Matsumoto; K H Barth; J B Selby; C J Tegtmeyer
Journal:  Cardiovasc Intervent Radiol       Date:  1993 May-Jun       Impact factor: 2.740

9.  Time dependent changes of arterial distensibility induced by cholesterol and balloon injury in rabbits: an in vivo intravascular ultrasound study.

Authors:  Michael Ribbing; Anja Dorszewski; Holger Reinecke; Günter Breithardt; Sebastian Kerber
Journal:  Int J Cardiovasc Imaging       Date:  2002-12       Impact factor: 2.357

10.  Iliac and femoropopliteal vascular occlusive disease treated with flexible tantalum stents.

Authors:  E P Strecker; B Hagen; D Liermann; B Schneider; H R Wolf; J Wambsganss
Journal:  Cardiovasc Intervent Radiol       Date:  1993 May-Jun       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.